Abstract
The interaction of dihydrofolate reductase (DHFR) from Escherichia coli with drugs such as methotrexate (MTX)and 2, 4-diamino-6, 7-dimethylpteridine (DAM) has been studied by means of site-directed mutagenesis, fluorescence spectroscopy, and steady-state as well as transient kinetics. A strictly conserved residue at the dihydrofolate binding site of DHFR, phenylalanine-31, has been replaced with tyrosine or valine to ascertain the importance for binding of this hydrophobic amino acid, which interacts with both the pteridine ring and the p-aminobenzoyl moiety. The first mutation (Phe-31 → Tyr) has a minimal effect on the binding of the classical inhibitor, DAM. On the other hand, the second mutation (Phe-31 → Val) has increased the dissociation constant of DAM from the DHFR.NADPH.DAM ternary complex over 150-fold (>3 kcal/mol). The dissociation constant of DAM from the (Val31-DHFR). DAM binary complex was too large to be measured fluorometrically. More importantly, these mutations have decreased the overall tight binding of MTX, from 100- to 140-fold (corresponding to a loss of binding energy of 2.2-2.4 kcal/mol) for the Tyr-31 and Val-31 mutants, respectively. These results indicate that hydrophobic interactions between MTX and DHFR are at least as important as formation of the MTX.DHFR salt bridge in the tight binding of MTX.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 129-137 |
| Number of pages | 9 |
| Journal | Journal of Medicinal Chemistry |
| Volume | 31 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 1988 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Drug Discovery
Fingerprint
Dive into the research topics of 'Evaluation of the Importance of Hydrophobic Interactions in Drug Binding to Dihydrofolate Reductase'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver